Cyclo Therapeutics Inc (NQ: CYTH )
0.7477
-0.0222
(-2.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Cyclo Therapeutics Inc
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20240826844634/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://ml.globenewswire.com/media/54cbaf70-16fe-4ac1-8956-c2d21ff8ae45/small/firm-logo-with-investor-law-firm-jpg.jpg)
![](https://mms.businesswire.com/media/20240822389933/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/55d96255-7830-4135-9e23-58cd61392f71/small/rafael-png.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/55d96255-7830-4135-9e23-58cd61392f71/small/rafael-png.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/55d96255-7830-4135-9e23-58cd61392f71/small/rafael-png.png)
Via GlobeNewswire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/55d96255-7830-4135-9e23-58cd61392f71/small/rafael-png.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
November 21, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
November 15, 2023
Via Business Wire
![](https://ml.globenewswire.com/media/55d96255-7830-4135-9e23-58cd61392f71/small/rafael-png.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cyclo Therapeutics to Present at 8th Annual Dawson James Conference
October 05, 2023
Via Business Wire
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://mms.businesswire.com/media/20230921055867/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
August 15, 2023
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.